An in vivo pharmacological analysis of benzomorphan binding sites in rats.
D000818:Animals; D001575:Benzomorphans / Q000494:pharmacology*; D001839:Bombesin / Q000494:pharmacology; D001921:Brain / Q000187:drug effects*; D003496:Cyclazocine / Q000031:analogs & derivatives / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D016314:Ethylketocyclazocine; D006120:Grooming / Q000187:drug effects; D006801:Humans; D008297:Male; D009019:Morphinans / Q000494:pharmacology*; D009020:Morphine / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D009294:Narcotics / Q000494:pharmacology; D010620:Phenazocine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011957:Receptors, Opioid / Q000187:drug effects*; D013237:Stereoisomerism; D013239:Stereotyped Behavior / Q000187:drug effects
D001575:Benzomorphans; D009019:Morphinans; D009294:Narcotics; D011957:Receptors, Opioid; D009270:Naloxone; D016314:Ethylketocyclazocine; D009020:Morphine; D010620:Phenazocine; D003496:Cyclazocine; D001839:Bombesin